By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intercept Pharmaceuticals 

450 W 15th Street
Suite 505
New York City  New York  10011  U.S.A.
Phone: 646-747-1000 Fax: 646-747-1001



Company News
Intercept Pharma (ICPT) To Report Second Quarter 2015 Financial Results On August 5 And Present At Upcoming Conferences 7/30/2015 7:58:54 AM
Intercept Pharma (ICPT) Appoints Richard Kim As Senior Vice President, Commercial Head Of U.S. 7/22/2015 7:18:04 AM
Intercept Pharma (ICPT) Submits Applications In The U.S. And Europe For Marketing Approval Of Obeticholic Acid For The Treatment Of Primary Biliary Cirrhosis 6/30/2015 7:21:55 AM
Intercept Pharma (ICPT) Appoints Juan Carlos Lopez-Talavera, M.D., Ph.D. As Senior Vice President Of Medical Affairs 6/22/2015 11:48:29 AM
Intercept Pharmaceuticals (ICPT) Announces First Quarter 2015 Financial Results 5/11/2015 8:23:11 AM
Intercept Pharmaceuticals (ICPT) To Report First Quarter 2015 Financial Results On May 11 And Present At Upcoming Conferences 5/4/2015 2:41:59 PM
Intercept Pharmaceuticals (ICPT) Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution And Cirrhosis Prevention In High-Risk NASH Patients 4/23/2015 9:46:31 AM
Intercept Pharmaceuticals (ICPT) Announces New Data In PBC And NASH To Be Presented At EASL 2015 4/13/2015 7:59:48 AM
Intercept Pharmaceuticals (ICPT) Announces Completion Of Public Offering 4/7/2015 7:11:08 AM
Intercept Pharmaceuticals (ICPT) Announces Pricing Of Public Offering Of Common Stock 3/31/2015 10:59:42 AM